Skip to main navigation Skip to search Skip to main content

Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial

  • SMART-DECISION investigators
  • University Ilsan-Paik Hospital
  • Chonnam National University
  • Samsung Changwon Hospital
  • Yonsei University Wonju College of Medicine
  • Kyung Hee University
  • Presbyterian Medical Center
  • Chungbuk National University
  • Kangwon National University
  • Keimyung University
  • St. Carollo Hospital
  • Jeju National University
  • Soonchunhyang University
  • Chungnam National University
  • Ewha Womans University
  • Seoul National University
  • Gyeongsang National University
  • Dankook University
  • Jeonbuk National University
  • University of Ulsan
  • Kangbuk Samsung Hospital
  • Korea University
  • The Catholic University of Korea
  • Chosun University
  • Chuncheon Sacred Heart Hospital
  • Johns Hopkins University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Discontinuation of β-blocker therapy in stabilised patients after acute myocardial infarction (SMART-DECISION): rationale and design of the randomised controlled trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry